Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Looking Into Biogen's Recent Short Interest
August 08, 2023
Tickers
BIIB
Tags
Market News
Short Ideas
BZI/SHORTHIST
From
Benzinga
Is Sage Therapeutics a Contrarian Buy?
August 08, 2023
Tickers
BIIB
SAGE
Tags
Market News
SAGE
Recent Press Releases
From
Motley Fool
DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
August 08, 2023
Tickers
AXSM
BIIB
CHGG
COIN
Tags
GENI
analyst forecasts
Small Cap
From
Benzinga
What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
August 07, 2023
Tickers
BIIB
SAGE
Tags
Price Target
Movers
News
From
Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
Tickers
AXSM
BIIB
PRAX
RLMD
Tags
General
SAGE
Briefs
From
Benzinga
Sage Therapeutics’ stock drops 49% after FDA approves zuranolone for postpartum depression but not for major depressive disorder
August 07, 2023
Tickers
BIIB
SAGE
Tags
BIIB
SAGE
From
MarketWatch
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
August 07, 2023
Tickers
AAPL
BIIB
BNTX
EADSY
Tags
EADSY
THS
SAGE
From
Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
August 07, 2023
Tickers
BIIB
SAGE
Tags
Health Care
BIIB
Biotech
From
Benzinga
FDA approves first-ever pill for postpartum depression in new mothers
August 04, 2023
Tickers
BIIB
SAGE
SPX
Tags
SPX
BIIB
SAGE
From
MarketWatch
Biogen Unusual Options Activity For August 02
August 02, 2023
Tickers
BIIB
Tags
Options
Benzinga
BIIB
From
Benzinga
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
August 02, 2023
Tickers
BIIB
CRSP
MRNA
Tags
Stocks to Buy
Market News
CRSP
From
InvestorPlace
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Tickers
BIIB
GILD
REGN
RETA
Tags
GILD
Market News
Stocks to Buy
From
InvestorPlace
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Tickers
BIIB
ESALY
RETA
Tags
ESALY
Market News
RETA
From
Motley Fool
Here's How Much You Would Have Made Owning Biogen Stock In The Last 15 Years
July 31, 2023
Tickers
BIIB
Tags
Dividends
BIIB
Benzinga
From
Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
July 31, 2023
Tickers
BIIB
DGX
ESALF
LLY
Tags
BIIB
LLY
ESALF
From
MarketWatch
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
July 31, 2023
Tickers
AAL
ADM
AMGN
AMT
Tags
VNQ
ADM
DHR
From
Benzinga
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
July 31, 2023
Tickers
BIIB
LLY
Tags
BIIB
Recent Press Releases
LLY
From
Motley Fool
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
Tickers
BBIO
BIIB
PFE
RETA
Tags
PFE
RETA
BBIO
From
Motley Fool
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
July 30, 2023
Tickers
BIIB
BMY
ESAIY
EXAI
Tags
Market News
Stocks to Buy
EXAI
From
InvestorPlace
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
July 29, 2023
Tickers
BIIB
EXEL
ILMN
Tags
Stocks to Buy
EXEL
ILMN
From
InvestorPlace
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
Tickers
AMGN
BIIB
DSGN
HZNP
Tags
BIIB
Large Cap
Benzinga
From
Benzinga
Health Care Company Biogen Announces Acquisition of Reata Pharmaceuticals
July 28, 2023
Tickers
BIIB
RETA
Tags
M&A
General
BIIB
From
Benzinga
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
July 28, 2023
Tickers
AZN
BIIB
PFE
RETA
Tags
AZN
SPX
PFE
From
MarketWatch
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
July 28, 2023
Tickers
BIIB
ENPH
PLTR
RETA
Tags
ENPH
Market News
XPEV
From
InvestorPlace
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
July 28, 2023
Tickers
BIIB
RETA
Tags
Large Cap
Biotech
BIIB
From
Benzinga
Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering
July 28, 2023
Tickers
BIIB
RETA
SPX
XBI
Tags
SPX
BIIB
RETA
From
MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Tickers
AURA
BA
BIDU
BIIB
Tags
EYE
Analyst Ratings
CVNA
From
Benzinga
I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO
July 27, 2023
Tickers
BIIB
Tags
Market News
BIIB
Recent Press Releases
From
Motley Fool
Why Sage Therapeutics Stock Is Tumbling Today
July 26, 2023
Tickers
BIIB
SAGE
Tags
Market News
SAGE
BIIB
From
Motley Fool
Analyst Ratings for Biogen
July 26, 2023
Tickers
BIIB
Tags
Market News
Analyst Ratings
BIIB
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.